KIF3B and prostate cancer: KIF3B has been shown to be over-expressed in multiple human cancers, such as gastric cancer, oral squamous cell carcinoma, pancreatic cancer, prostate cancer, seminoma, hepatocellular carcinoma, and acute lymphoblastic leukemia (34–40).